An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies
Top Cited Papers
Open Access
- 31 January 2020
- journal article
- editorial
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 9 (1) , 275-277
- https://doi.org/10.1080/22221751.2020.1723441
Abstract
In December of 2019, an outbreak of pneumonia caused by an unknown aetiology occurred in Wuhan, China and most patients were linked to a single seafood market, which reportedly sold seafood and som...Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (NIH / R01AI139092)
This publication has 15 references indexed in Scilit:
- A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spikeScience Advances, 2019
- Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding DomainViruses, 2019
- Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese batsEmerging Microbes & Infections, 2018
- Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronavirusesScience China Life Sciences, 2017
- A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike proteinEmerging Microbes & Infections, 2017
- MERS-CoV spike protein: a key target for antiviralsEmerging Therapeutic Targets, 2016
- Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccinesNature Communications, 2016
- Evaluation of candidate vaccine approaches for MERS-CoVNature Communications, 2015
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitorsPublished by Elsevier ,2004